ALOX5 and neoplasm: Based on this information, Bachi et al. [3] showed that the peritumoral treatment with EPA, as well as with leukotriene B5 (LTB5), the main mediator derived from EPA after 5-LOX activity, was able to reduce tumor growth in our experimental model.